362 related articles for article (PubMed ID: 12794814)
1. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.
Silverman GJ; Weisman S
Arthritis Rheum; 2003 Jun; 48(6):1484-92. PubMed ID: 12794814
[No Abstract] [Full Text] [Related]
2. Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.
Kazkaz H; Isenberg D
Curr Opin Pharmacol; 2004 Aug; 4(4):398-402. PubMed ID: 15251135
[TBL] [Abstract][Full Text] [Related]
3. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
Looney RJ
Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseases.
Lee S; Ballow M
J Allergy Clin Immunol; 2010 Apr; 125(4):814-20. PubMed ID: 20371395
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD20 therapy and autoimmune disease: therapeutic opportunities and evolving insights.
Silverman GJ
Front Biosci; 2007 Jan; 12():2194-206. PubMed ID: 17127456
[TBL] [Abstract][Full Text] [Related]
6. B cell-targeted therapy in diseases other than rheumatoid arthritis.
Looney RJ
J Rheumatol Suppl; 2005 Feb; 73():25-8; discussion 29-30. PubMed ID: 15693113
[TBL] [Abstract][Full Text] [Related]
7. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
8. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
Levesque MC; St Clair EW
J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
[TBL] [Abstract][Full Text] [Related]
9. Prospects for B-cell-targeted therapy in autoimmune disease.
Edwards JC; Cambridge G
Rheumatology (Oxford); 2005 Feb; 44(2):151-6. PubMed ID: 15509628
[No Abstract] [Full Text] [Related]
10. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
[TBL] [Abstract][Full Text] [Related]
11. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
12. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
Fox DA; McCune WJ
Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
[No Abstract] [Full Text] [Related]
13. A review of the current use of rituximab in autoimmune diseases.
Gürcan HM; Keskin DB; Stern JN; Nitzberg MA; Shekhani H; Ahmed AR
Int Immunopharmacol; 2009 Jan; 9(1):10-25. PubMed ID: 19000786
[TBL] [Abstract][Full Text] [Related]
14. [Rituximab in systemic lupus erythematosus. Part I. Theoretical basis].
Kardynał A; Rudnicka L
Pol Merkur Lekarski; 2010 Aug; 29(170):131-4. PubMed ID: 20842829
[TBL] [Abstract][Full Text] [Related]
15. B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
Edwards JC; Cambridge G
Nat Rev Immunol; 2006 May; 6(5):394-403. PubMed ID: 16622478
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of autoimmune thrombocytopenic purpura with rituximab in a dialysis patient with systemic lupus erythematosus.
Lee SY; Hsu PY; Juan KC; Chang H; Huang WH; Lai PC
Int Immunopharmacol; 2010 May; 10(5):632-4. PubMed ID: 20172055
[TBL] [Abstract][Full Text] [Related]
17. [CD20 antibody for the treatment of systemic autoimmune diseases].
Tanaka Y
Nihon Rinsho; 2005 May; 63 Suppl 5():728-33. PubMed ID: 15954437
[No Abstract] [Full Text] [Related]
18. B cells move to centre stage: novel opportunities for autoimmune disease treatment.
Browning JL
Nat Rev Drug Discov; 2006 Jul; 5(7):564-76. PubMed ID: 16816838
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
Goldblatt F; Isenberg DA
Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
[TBL] [Abstract][Full Text] [Related]
20. B cell depletion in autoimmune disease.
Gorman C; Leandro M; Isenberg D
Arthritis Res Ther; 2003; 5 Suppl 4(Suppl 4):S17-21. PubMed ID: 15180893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
